Stay updated with breaking news from Idrx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for the industry's most promising up-and-coming...
DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Stromal Tumors - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.The "Gastrointestinal Stromal Tumors - Pipeline Insight, 2022," report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointest...
-- Achieved $36.5 million in total revenues, including $28.5 million in AYVAKIT® (avapritinib) net product revenues representing 20 percent AYVAKIT revenue...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!